Execution of an Agreement with APITCO Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has clarified that its earlier announcement incorrectly stated the agreement date as 18 July 2025 — that was actually the date of proposal, not execution. The Service Agreement with APITCO Limited, a Public Sector Undertaking, was actually executed on 25 July 2025. Under the agreement, Shukra will act as a Business Associate / Healthcare Project Management Consultant and Service & Training Provider for various Healthcare Government assignments. There is no cross-shareholding between the two parties, and APITCO is not related to Shukra's promoters in any way.
This is largely a procedural clarification correcting the execution date rather than a new material development. The underlying collaboration with a PSU could open up new revenue streams from government healthcare projects, but no specific financial numbers or deal value have been disclosed, so near-term stock impact is likely limited.